Navigation Links
A milestone for new carbon-dioxide capture/clean coal technology
Date:3/20/2013

An innovative new process that releases the energy in coal without burning while capturing carbon dioxide, the major greenhouse gas has passed a milestone on the route to possible commercial use, scientists are reporting. Their study in the ACS journal Energy & Fuels describes results of a successful 200-hour test on a sub-pilot scale version of the technology using two inexpensive but highly polluting forms of coal.

Liang-Shih Fan and colleagues explain that carbon capture and sequestration ranks high among the approaches for reducing coal-related emissions of the carbon dioxide linked to global warming. This approach involves separating and collecting carbon dioxide before it leaves smokestacks. Fan's team has been working for more than a decade on two versions of carbon capture termed Syngas Chemical Looping (SCL) and Coal-Direct Chemical Looping (CDCL). They involve oxidizing coal, syngas or natural gas in a sealed chamber in the absence of the atmospheric oxygen involved in conventional burning. Metal compounds containing oxygen are in the chamber. They provide the oxygen for oxidation, take up coal's energy, release it as heat in a second chamber and circulate back for another run in the first chamber.

Their report describes the longest continuous operation of the CDCL test system. It operated successfully for 200 hours without an involuntary shutdown. The system used sub-bituminous and lignite coals, which are the main source of carbon dioxide emissions at U.S. coal-fired power plants. Carbon dioxide captured during operation had a purity of 99.5 percent.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Xenon Receives a Milestone Payment for Marketing Approval of Glybera in Europe
2. New milestone book documents changes in the south Florida marine ecosystem
3. Lab-engineered kidney project reaches early milestone
4. 17th century Dutch explorers help the Atlas reach a major milestone -- 30 million records
5. Mobile LIDAR technology expanding rapidly
6. Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities
7. Wayne State vision restoration technology receives Notice of Allowance for US patent app
8. WPI Biomedical Technology in final 4 of international business plan contest
9. Nottingham technology in heart development breakthrough
10. Top 10 ways biotechnology could improve our everyday life
11. Research secured for the future: Pensoft Publishers takes on CLOCKSS archival technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today is providing ... its previously announced rights offering of up to ... stock and Series C Convertible Preferred Stock to ... As previously announced, the rights offering ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
Breaking Biology Technology: